β-lactam susceptibility in extended-spectrum β-lactamase-producing isolates
Main Authors: | Gopal Nandlal Agrawal, Hina Dilipsingh Rahangdale, Aparajit W Walawalkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Pathology and Microbiology |
Online Access: | http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2017;volume=60;issue=1;spage=142;epage=143;aulast=Agrawal |
Similar Items
-
Role of β−lactamase in the susceptibility of clinical isolates to β−lactam antibiotics
by: A. Soebandrio, et al.
Published: (2004-08-01) -
Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
by: Allison M. Gibble, et al.
Published: (2015-12-01) -
Reduced susceptibility to extended-spectrum β-lactams in V. cholerae isolated in Bangladesh
by: Daniela Ceccarelli, et al.
Published: (2016-10-01) -
Analysis of Extended-Spectrum-β-Lactamases and Non- Extended-Spectrum-β-Lactamases of Klebsiella pneumoniae isolates in Taiwan
by: Hsiu-Mei Wu, et al.
Published: (2006) -
Molecular epidemiology and drug susceptibilities of extended-spectrum β-lactamase–producing Klebsiella pneumoniae
by: Yung-Cheng Huang, et al.
Published: (2005)